Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mascher

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Arzneimittel-Forschung|April 1, 1995
Pharmacokinetics and bioavailability of different formulations of aciclovirH Vergin, C Kikuta, H Mascher, et al.
Acta Physiologica (Oxford, England)|March 10, 2011
Enhanced rates of muscle protein synthesis and elevated mTOR signalling following endurance exercise in human subjectsH Mascher, B Ekblom, O Rooyackers, et al.
Arzneimittel-Forschung|September 1, 1986
Pharmacokinetics and bioequivalence of different formulations of pirenzepineH Vergin, H Mascher, K Strobel, et al.
Arzneimittel-Forschung|June 1, 1997
Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in ratsS Walser, R Hruby, E Hesse, et al.
Acta Physiologica (Oxford, England)|May 10, 2007
Changes in signalling pathways regulating protein synthesis in human muscle in the recovery period after endurance exerciseH Mascher, H Andersson, P-A Nilsson, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
Pharmacokinetics of dexibuprofen administered as 200 mg and 400 mg film-coated tablets in healthy volunteersN Eller, C J Kollenz, H Schiel, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1999
Comparison of the pharmacodynamics and pharmacokinetics of pantoprazole (40 mg) as compared to omeprazole MUPS (20 mg) after repeated oral dose administrationA Ehrlich, P W Lücker, A Wiedemann, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 21, 2004
Topical skin penetration of diclofenac after single- and multiple-dose applicationP Dehghanyar, B X Mayer, K Namiranian, et al.
Neurology|February 1, 1993
Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptorB Schmitt, B Steinmann, R Gitzelmann, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofenB Gabard, G Nirnberger, H Schiel, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Arzneimittel-Forschung|April 1, 1995
Pharmacokinetics and bioavailability of different formulations of aciclovirH Vergin, C Kikuta, H Mascher, et al.
Acta Physiologica (Oxford, England)|March 10, 2011
Enhanced rates of muscle protein synthesis and elevated mTOR signalling following endurance exercise in human subjectsH Mascher, B Ekblom, O Rooyackers, et al.
Arzneimittel-Forschung|September 1, 1986
Pharmacokinetics and bioequivalence of different formulations of pirenzepineH Vergin, H Mascher, K Strobel, et al.
Arzneimittel-Forschung|June 1, 1997
Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in ratsS Walser, R Hruby, E Hesse, et al.
Acta Physiologica (Oxford, England)|May 10, 2007
Changes in signalling pathways regulating protein synthesis in human muscle in the recovery period after endurance exerciseH Mascher, H Andersson, P-A Nilsson, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
Pharmacokinetics of dexibuprofen administered as 200 mg and 400 mg film-coated tablets in healthy volunteersN Eller, C J Kollenz, H Schiel, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1999
Comparison of the pharmacodynamics and pharmacokinetics of pantoprazole (40 mg) as compared to omeprazole MUPS (20 mg) after repeated oral dose administrationA Ehrlich, P W Lücker, A Wiedemann, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 21, 2004
Topical skin penetration of diclofenac after single- and multiple-dose applicationP Dehghanyar, B X Mayer, K Namiranian, et al.
Neurology|February 1, 1993
Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptorB Schmitt, B Steinmann, R Gitzelmann, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofenB Gabard, G Nirnberger, H Schiel, et al.
Pageof 5